167 related articles for article (PubMed ID: 23041549)
1. Oxidative stress-regulated lentiviral TK/GCV gene therapy for lung cancer treatment.
Leinonen HM; Ruotsalainen AK; Määttä AM; Laitinen HM; Kuosmanen SM; Kansanen E; Pikkarainen JT; Lappalainen JP; Samaranayake H; Lesch HP; Kaikkonen MU; Ylä-Herttuala S; Levonen AL
Cancer Res; 2012 Dec; 72(23):6227-35. PubMed ID: 23041549
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of HSV-tk suicide gene therapy driven by the Grp78 stress-inducible promoter in esophagogastric junction and gastric adenocarcinomas.
Azatian A; Yu H; Dai W; Schneiders FI; Botelho NK; Lord RV
J Gastrointest Surg; 2009 Jun; 13(6):1044-51. PubMed ID: 19277794
[TBL] [Abstract][Full Text] [Related]
3. STAT3/NF-κB-Regulated Lentiviral TK/GCV Suicide Gene Therapy for Cisplatin-Resistant Triple-Negative Breast Cancer.
Kuo WY; Hwu L; Wu CY; Lee JS; Chang CW; Liu RS
Theranostics; 2017; 7(3):647-663. PubMed ID: 28255357
[TBL] [Abstract][Full Text] [Related]
4. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
Tang Q; Zhang D; Wan M; Jin L
Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
[TBL] [Abstract][Full Text] [Related]
5. [An experimental study on targeting suicide gene therapy for lung cancer with HSV-TK driven by hTERT promoter].
Wang YP; Tang XJ; Zhou QH; Che GW; Chen XH; Zhu DX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):701-5. PubMed ID: 19024294
[TBL] [Abstract][Full Text] [Related]
6. [HSV-TK gene therapy of lung adenocarcinoma xenografts using a hypoxia/radiation dual-sensitive promoter].
Wang WD; Chen ZT; Li DZ; Duan YZ; Wang ZX; Cao ZH
Ai Zheng; 2004 Jul; 23(7):788-93. PubMed ID: 15248913
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated suicide gene therapy under the control of Cox-2 promoter for colorectal cancer.
Wang ZX; Bian HB; Yang JS; De W; Ji XH
Cancer Biol Ther; 2009 Aug; 8(15):1480-8. PubMed ID: 19571664
[TBL] [Abstract][Full Text] [Related]
8. Resistance developing after long-term ganciclovir prodrug treatment in a preclinical model of NSCLC.
Kurdow R; Schniewind B; Boehle AS; Haye S; Boenicke L; Dohrmann P; Kalthoff H
Anticancer Res; 2004; 24(2B):827-31. PubMed ID: 15161034
[TBL] [Abstract][Full Text] [Related]
9. Gene Therapy for Human Lung Adenocarcinoma Using a Suicide Gene Driven by a Lung-Specific Promoter Delivered by JC Virus-Like Particles.
Chao CN; Lin MC; Fang CY; Chen PL; Chang D; Shen CH; Wang M
PLoS One; 2016; 11(6):e0157865. PubMed ID: 27322500
[TBL] [Abstract][Full Text] [Related]
10. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.
Kajiwara E; Kawano K; Hattori Y; Fukushima M; Hayashi K; Maitani Y
J Control Release; 2007 Jul; 120(1-2):104-10. PubMed ID: 17509714
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
[TBL] [Abstract][Full Text] [Related]
12. Using HSV-TK/GCV suicide gene therapy to inhibit lens epithelial cell proliferation for treatment of posterior capsular opacification.
Jiang YX; Lu Y; Liu TJ; Yang J; Chen Y; Fang YW
Mol Vis; 2011 Jan; 17():291-9. PubMed ID: 21283526
[TBL] [Abstract][Full Text] [Related]
13. Killing effect of the herpes simplex virus thymidine kinase/ganciclovir enzyme/prodrug system on human nasopharyngeal carcinoma cells.
Tang Y; Li J; Zhao S; Liu J
J Int Med Res; 2007; 35(4):433-41. PubMed ID: 17697519
[TBL] [Abstract][Full Text] [Related]
14. Lentiviral HSV-Tk.007-mediated suicide gene therapy is not toxic for normal brain cells.
Hossain JA; Ystaas LR; Mrdalj J; Välk K; Riecken K; Fehse B; Bjerkvig R; Grønli J; Miletic H
J Gene Med; 2016 Sep; 18(9):234-43. PubMed ID: 27490042
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of lentivirus-mediated and MUC1 antibody-targeted VP22-TK/GCV suicide gene therapy for ovarian cancer.
Kong B; Wang W; Liu C; Song L; Ma D; Qu X; Jiang J; Yang X; Zhang Y; Wang B; Wei MQ; Yang Q
In Vivo; 2003; 17(2):153-6. PubMed ID: 12792977
[TBL] [Abstract][Full Text] [Related]
16. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
Wildner O; Morris JC
Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
[TBL] [Abstract][Full Text] [Related]
17. Intravenous Administration Is an Effective and Safe Route for Cancer Gene Therapy Using the Bifidobacterium-Mediated Recombinant HSV-1 Thymidine Kinase and Ganciclovir.
Zhou H; He Z; Wang C; Xie T; Liu L; Liu C; Song F; Ma Y
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27275821
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene.
Osaki T; Tanio Y; Tachibana I; Hosoe S; Kumagai T; Kawase I; Oikawa S; Kishimoto T
Cancer Res; 1994 Oct; 54(20):5258-61. PubMed ID: 7923150
[TBL] [Abstract][Full Text] [Related]
19. [Hypoxia responsive element regulated herpes simplex virus-thymidine kinase system enhances killing effect of gancyclovir on Ewing's sarcoma cell line under hypoxic condition].
Si YJ; Guang LX; Yuan FH; Zhang KB
Zhonghua Er Ke Za Zhi; 2006 Aug; 44(8):616-20. PubMed ID: 17083794
[TBL] [Abstract][Full Text] [Related]
20. Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase-ganciclovir gene therapy.
Määttä AM; Tenhunen A; Pasanen T; Meriläinen O; Pellinen R; Mäkinen K; Alhava E; Wahlfors J
Int J Oncol; 2004 Apr; 24(4):943-9. PubMed ID: 15010834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
